Eur J Cancer. 2006 Mar;42(5):582-8. Epub 2006 Jan 20.

Recent developments in the use of chemotherapy in brain tumours.

Source

Department of Neuro-Oncology, Daniel den Hoed Cancer Center/Erasmus University Hospital Rotterdam, P.O. Box 5201, 3008AE Rotterdam, The Netherlands. m.vandenbent@erasmusmc.nl

Abstract

Several recent studies have further clarified the role of chemotherapy in newly diagnosed anaplastic glioma. For newly diagnosed glioblastoma, combined daily radiotherapy with daily temozolomide followed by six cycles of adjuvant temozolomide improves overall survival. This benefit is especially observed in patients with a methylated promotor of the MGMT gene which encodes an alkyltransferase; this observation however, needs confirmation. Although oligodendroglial tumours are sensitive to chemotherapy, classical adjuvant nitrosourea-based chemotherapy does not improve overall survival in newly diagnosed anaplastic oligodendroglioma, even in the subset of 1p/19q loss tumours. It may increase progression-free survival however, and further studies must show if combined modality treatment with daily chemotherapy during radiotherapy increases survival. Trials exploring the role of chemotherapy in low-grade glioma are ongoing. No standard chemotherapy is currently available for highly anaplastic glioma failing first-line temozolomide-based therapy.

PMID:: 16427778; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

DACARBAZINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. [Health Technol Assess. 2007]
Review The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K. Health Technol Assess. 2007 Nov; 11(45):iii-iv, ix-221.
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. [J Neurooncol. 2006]
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
Broniscer A, Chintagumpala M, Fouladi M, Krasin MJ, Kocak M, Bowers DC, Iacono LC, Merchant TE, Stewart CF, Houghton PJ, et al. J Neurooncol. 2006 Feb; 76(3):313-9.
Review Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. [Cancer Invest. 2007]
Review Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
Schiff D. Cancer Invest. 2007 Dec; 25(8):776-84. Epub 2007 Oct 18.
[Chemotherapy for brain tumors in adult patients]. [Nervenarzt. 2008]
[Chemotherapy for brain tumors in adult patients].
Weller M. Nervenarzt. 2008 Feb; 79(2):231-41.
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. [Eur J Cancer. 2006]
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven MC, Kros JM, French PJ, Biemond-ter Stege EM, Graveland WJ, Taphoorn MJ, Brandes AA, van den Bent MJ. Eur J Cancer. 2006 Oct; 42(15):2499-503. Epub 2006 Aug 17.

See reviews... See all...

Cited by 6 PubMed Central articles

Direct DNA methylation profiling using methyl binding domain proteins. [Anal Chem. 2010]
Direct DNA methylation profiling using methyl binding domain proteins.
Yu Y, Blair S, Gillespie D, Jensen R, Myszka D, Badran AH, Ghosh I, Chagovetz A. Anal Chem. 2010 Jun 15; 82(12):5012-9.
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients. [Neuro Oncol. 2010]
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.
Spiegl-Kreinecker S, Pirker C, Filipits M, Lötsch D, Buchroithner J, Pichler J, Silye R, Weis S, Micksche M, Fischer J, et al. Neuro Oncol. 2010 Jan; 12(1):28-36. Epub 2009 Oct 15.
Review Experience with irinotecan for the treatment of malignant glioma. [Neuro Oncol. 2009]
Review Experience with irinotecan for the treatment of malignant glioma.
Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS. Neuro Oncol. 2009 Feb; 11(1):80-91. Epub 2008 Sep 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Recent developments in the use of chemotherapy in brain tumours.
Recent developments in the use of chemotherapy in brain tumours.
Eur J Cancer. 2006 Mar ;42(5):582-8. Epub 2006 Jan 20 .

PubMed
The use of sparse CT datasets for auto-generating accurate FE models of the femu...
The use of sparse CT datasets for auto-generating accurate FE models of the femur and pelvis.
J Biomech. 2007 ;40(1):26-35. Epub 2006 Jan 20 .

PubMed
Gender and geographic influence on the racial disparity in bladder cancer mortal...
Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.
J Am Coll Surg. 2006 Feb ;202(2):284-90. Epub 2005 Dec 19 .

PubMed
Continuous ASL perfusion fMRI investigation of higher cognition: quantification ...
Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks.
Neuroimage. 2006 May 15 ;31(1):376-85. Epub 2006 Jan 19 .

PubMed
Characterization of displaced white matter by brain tumors using combined DTI an...
Characterization of displaced white matter by brain tumors using combined DTI and fMRI.
Neuroimage. 2006 May 1 ;30(4):1100-11. Epub 2006 Jan 19 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: